Roche announces FDA approval of Tamiflu for the treatment of influenza in infants
22 December 2012 | By Roche
First medicine approved to treat influenza in infants two weeks of age and older...
List view / Grid view
News
Novartis drug Exjade® approved by European Commission for iron overload in patients with non-transfusion-dependent thalassemia
21 December 2012 | By Novartis
The EC has approved Exjade®...
Biogen Idec forms first-of-its-kind research consortium to identify ALS drug targets
20 December 2012 | By Biogen Idec
Biogen Idec has created a new research consortium...
Top-line six-month primary treatment period results from first Phase III Fabry monotherapy study
19 December 2012 | By GlaxoSmithKline
Six-month primary treatment period results...
The final phase 3a trial for IDegLira completed, and FIAsp approved for phase 3 development
19 December 2012 | By Novo Nordisk
Novo Nordisk announced the completion of the phase 3a programme for IDegLira...
Merck and GE Healthcare collaborate on use of imaging biomarkers for investigational BACE inhibitor clinical development program
18 December 2012 | By Merck
Clinical study collaboration announced...
GSK and Theravance announce regulatory submission for UMEC/VI (LAMA/LABA) in the US
18 December 2012 | By GlaxoSmithKline
ANORO ELLIPTA™ proposed proprietary name for UMEC/VI...
Sanofi President, Global Operations, to retire
18 December 2012 | By Sanofi
Sanofi announced that Hanspeter Spek, President, Global Operations, will retire from his current role in mid-2013...
Roche launches new cobas b 101 system for management of metabolic syndrome
18 December 2012 | By Roche
Roche announced the global launch (excluding US) of cobas b 101...
Abbott announces new testosterone test to measure the hormone at low levels
17 December 2012 | By Abbott
New assay measures testosterone levels to help diagnose related conditions...
ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada
17 December 2012 | By GlaxoSmithKline
“These regulatory submissions are an important step for ViiV Healthcare..."
Teva enters agreement with Handok to establish business venture with significant presence in Korean pharmaceutical market
16 December 2012 | By Teva Pharmaceutical Industries Ltd
TEVA and Handok announced agreement...
Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing’s disease, a serious endocrine disorder
15 December 2012 | By Novartis
The US FDA has approved Signifor®...
Genzyme and Isis provide update on CHMP opinion on KYNAMRO™ (mipomersen)
14 December 2012 | By Sanofi
"We are disappointed by the Committee's recommendation..."
Roche’s breast cancer treatment Perjeta receives recommendation for approval in EU
14 December 2012 | By Roche
Positive opinion for the use of Perjeta (pertuzumab)...
